methyl (5Z)-5-ethylidene-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: methyl (5Z)-5-ethylidene-4-[2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate
• 化学式: C₂₅H₃₂O₁₂
• 分子量: 524.5
• InChiKey: GMQXOLRKJQWPNB-CLINQFSRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  37
• 可旋转键数：
  11
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  181
• 氢给体数：
  5
• 氢受体数：
  12

文献信息

• [EN] POLYPHENOLIC EXTRACT<br/>[FR] EXTRAIT POLYPHÉNOLIQUE
  申请人：BIO ACTOR BVBA

  公开号：WO2009132807A1

  公开（公告）日：2009-11-05

  The present invention is on particular compositions comprising certain combinations of the main olive polyphenols, such as for instance oleuropein and/or ligstroside in combination with hydroxytyrosol and/or tyrosol characterized in that the ratio of non-hydrolysed polyphenols (oleuropein and/or ligstroside) to hydrolysed polyphenols (hydroxytyrosol and/or tyrosol) is within certain thresholds which unexpectedly provide certain health benefits as compared to other compositions of olive polyphenols already known in the art. In a particular embodiment of the present invention the compositions contain standardized quantities for at least two of said olive polyphenols.